PRESS RELEASE

from H&R GmbH & Co. KGaA (isin : DE000A2E4T77)

H&R GmbH & Co. KGaA publishes Annual Report 2023

EQS-News: H&R GmbH & Co. KGaA / Key word(s): Annual Report/Annual Results
H&R GmbH & Co. KGaA publishes Annual Report 2023

28.03.2024 / 07:52 CET/CEST
The issuer is solely responsible for the content of this announcement.


H&R GmbH & Co. KGaA publishes annual report 2023

 

  • H&R confirms preliminary figures and ends financial year 2023 with EBITDA of EUR 92.7 million
  • Management will again propose a dividend payment of €0.10 per share to the Annual General Meeting

 

Salzbergen, Germany, March 28th, 2024. H&R GmbH & Co. KGaA (H&R KGaA; ISIN DE000A2E4T77) achieved an operating result (EBITDA - consolidated earnings before income taxes, other financial income and expenses as well as depreciation, amortization, impairment and write-ups of intangible assets and property, plant and equipment) of EUR 92.7 million for financial year 2023 (2022: EUR 124.9 million); (for the other earnings levels, see the "Key figures for H&R KGaA" table below). Below the line, consolidated net income attributable to shareholders amounted to EUR 10.6 million (2022: EUR 42.7 million). The result was achieved on sales revenues of EUR 1,352.3 million. This was EUR 223.7 million less than in the previous year (2022: EUR 1,576.0 million) due to price and volume factors.

 

 Key figures for H&R KGaA:

in million. €20232022- / +
    
Sales revenues1,352.31,576.0-223.7
Operating Result (EBITDA)92.7124.9-32.2
in % of sales revenues6.97.9-1.0
EBIT30.369.6-39.3
Earnings before taxes18.862.0-43.2
Consolidated earnings after taxes10.645.4-34.8
Consolidated net profit attributable to shareholders10.642.7-32.1
Earnings per share (€)0.281.15-0.87
Operative Cash flow119.138.081.1
    
 31.12.2331.12.22- / +
Balance Sheet total903,2962,1-58.9
Group Equity457,6471,2-13.6
Equity Ratio (in%)50,649,01.6
Employees (absolute)1,7041,63173

Key figures for segments

in million. €20232022- / +
    
Sales Revenues   
ChemPharm Refining828.21,020.6-192.4
ChemPharm Sales492.7526.7-34.0
Plastics51.349.02.3
Consolidation-20.0-20.30.3
    
EBITDA   
ChemPharm Refining58.192.7-34.6
ChemPharm Sales31.533.4-1.9
Plastics4.75.0-0.3
Consolidation-1.6-6.24.6

 

Dividend proposal to the Annual General Meeting planned

H&R GmbH & Co. KGaA has achieved a distributable result according to HGB for 2023. The company's management will again propose to the Annual General Meeting that a dividend of EUR 0.10 per share be distributed.

Outlook

We are currently formulating our expectations for 2024 with an operating result (EBITDA) in the range of € 90.0 million to € 110.0 million but reserve the right to adjust these expectations during the year and in consideration of further business developments. For a complete presentation of business performance, including segment reporting and the annual financial statements, H&R KGaA refers to the 2023 Annual Report published today at www.hur.com - Investors - Publications.

Contact:
H&R GmbH & Co. KGaA, Head of Investor Relations / Communication, Ties Kaiser
Neuenkirchener Straße 8, 48499 Salzbergen
Phone.: +49 40 43218-321, Fax: +49 40 43218-390
Mail: ties.kaiser@hur.com
www.hur.com

H&R GmbH & Co. KGaA:

Listed in the Prime Standard of the Frankfurt Stock Exchange, H&R GmbH & Co. KGaA is a specialty chemicals company active in the development and manufacture of chemical-pharmaceutical specialty products based on fossil, bio-based, synthesized and recycled hydrocarbons and in the production of precision plastic parts.

 

Forward-looking statements and forecasts:

This insider information pursuant to Article 17 of the Market Abuse Regulation [MAR] contains forward-looking statements. The statements are based on the current estimates and forecasts by the Management Team and the information available to it at this time. These forward-looking statements do not provide any warranty for the future developments and results contained therein. The future developments and results are dependent on a number of factors; they entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this insider information pursuant to Article 17 of the MAR.

 



28.03.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language:English
Company:H&R GmbH & Co. KGaA
Neuenkirchener Str. 8
48499 Salzbergen
Germany
Phone:+49 (0)40 43 218 321
Fax:+49 (0)40 43 218 390
E-mail:investor.relations@hur.com
Internet:www.hur.com
ISIN:DE000A2E4T77
WKN:A2E4T7
Listed:Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID:1869337

 
End of NewsEQS News Service

1869337  28.03.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1869337&application_name=news&site_id=symex~~~af100301-a623-4c64-8f3d-90fc88eca9e6
See all H&R GmbH & Co. KGaA news